Adial Pharmaceuticals, Inc.
ADIL
$0.2454
$0.00642.68%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.23M | -2.07M | -2.19M | -2.46M | -6.48M |
| Total Depreciation and Amortization | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 249.80K | 364.00K | 219.30K | 424.90K | 4.88M |
| Change in Net Operating Assets | 393.40K | 252.80K | 278.30K | -114.80K | -30.10K |
| Cash from Operations | -1.59M | -1.45M | -1.69M | -2.15M | -1.63M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 150.00K | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 150.00K | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 50.60K | 0.00 | 3.61M | 411.10K | 3.82M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 50.60K | 0.00 | 3.61M | 411.10K | 3.82M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.38M | -1.45M | 1.92M | -1.74M | 2.20M |